Discover 43 paid clinical trials in Dothan, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 43
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: Dothan AL, Macon GA, Atlanta GA, Tampa FL, Flowood MS,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06588855
Phase3, Recruiting
Active & Responsive
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: Dothan AL, Roswell GA, Tampa FL, New Orleans LA,
Sponsor: Takeda
Sex: All
Age: 18 - 65
Code: NCT06095128
Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Dothan AL, Macon GA, Atlanta GA, Brooksville FL,
Get alerts for new trials in your area by subscribing now
Active & Responsive
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
for
Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer,
Location: Dothan AL, Grand Rapids MI, Omaha NE
Sponsor: Radiopharm Theranostics, Ltd
Sex: All
Age: 18+
Code: NCT07189871
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Dothan AL, Atlanta GA, Norcross GA, Jacksonville FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Dothan AL, Birmingham AL, Marietta GA, Atlanta GA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis